Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Adolescents (10-18 years) Adults (18+) anthrax Agenda & Minutes United States of America Pneumococcal disease Japanese encephalitis Human papillomavirus (HPV) Rabies Influenza Meningitis Pertussis Hepatitis A
Download:
evidence-based recommendations Kenya Influenza
Download:
Agenda & Minutes Argentina Poliomyelitis Measles Rubella Yellow fever Influenza Pneumococcal disease
Download:
Agenda & Minutes Argentina Dengue Pneumococcal disease Measles Rubella
Download:
anthrax supply shortage Agenda & Minutes United States of America Influenza Human papillomavirus (HPV) Mumps Herpes zoster Japanese encephalitis Pneumococcal disease
Download:
anthrax evidence-based recommendations Agenda & Minutes United States of America Hepatitis A Influenza Human papillomavirus (HPV) Pneumococcal disease Meningitis Japanese encephalitis
Download:
supply shortage meeting minutes Agenda & Minutes France Influenza Human papillomavirus (HPV) Tuberculosis
Download: